Elimination of Mother-to-Child Transmission Publications
Resource | Guidelines,
These are the first WHO guidelines on testing for chronic HBV and HCV infection and complement published guidance by WHO on the prevention, care and treatment of chronic HCV and HBV infection. The primary audience for these guidelines are national programme managers in ministries of health and health-care providers in low- and middle-income countries (LMICs) responsible for planning and implementing hepatitis testing, prevention, care and treatment services.
Resource | Publications,
This information note provides interim advice for countries using or planning to introduce dual HIV/syphilis rapid diagnostic test (RDT) in antenatal services and other testing sites pending forthcoming WHO programmatic guidance, including a WHO recommended testing strategy.
Resource | Publications,
In 2010 and 2014, World Health Assembly resolutions called for stronger surveillance of viral hepatitis. In response, the World Health Organization (WHO) has developed these technical considerations to assist and guide Member States in implementing and/or optimizing viral hepatitis surveillance.
Resource | Guidelines,
Syphilis is a condition which can be cured with penicillin treatment. Treatment of pregnant women having syphilis with penicillin treatment prevents congenital infection. Early identification and treatment of syphilis among females will reduce the risk of both sexual transmission and mother to child transmission.
Resource | Publications,
To monitor and evaluate the Global Health Sector Strategy (GHSS) on viral hepatitis, the World Health Organization (WHO) proposes a monitoring and evaluation framework. This framework should facilitate collection and analysis of standardized data with a balance between the need to remain parsimonious and obtain the minimum information required.
Resource | Publications,
In 2010 and 2014, World Health Assembly resolutions called for stronger surveillance of viral hepatitis. In response, the World Health Organization (WHO) has developed these technical considerations to assist and guide Member States in implementing and/or optimizing viral hepatitis surveillance.